Arcutis Biotherapeutics, Inc. (ARQT) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 3.69B |
| Enterprise Value | 3.66B |
| P/E Ratio | 130.53 |
| PEG Ratio | 0.02 |
| Price/Sales Ratio | 7.81 |
| Price/Book Ratio | 17.05 |
| Enterprise/Revenue | 7.98 |
| Enterprise/EBITDA | 85.25 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.06 |
| Operating Margin | 0.07 |
AD
Management Effectiveness
| Return On Assets | 0.06 |
| Return On Equity | 0.15 |
Income Statement
| Revenue | 376.07M |
| Revenue/Share | 3.55 |
| Gross Profit | 339.38M |
| EBITDA | 1.78M |
| Net Income | -16.14M |
| Diluted EPS | -0.13 |
Balance Sheet
| Total Cash | 238.55M |
| Total Cash/Share | 1.83 |
| Total Debt | 114.14M |
| Total Debt/Equity | 0.52 |
| Current Ratio | 2.92 |
| Book Value Per Share | 1.69 |
Price History
| 52-Week Change | 38.03 |
| 52-Week High | 31.77 |
| 52-Week Low | 19.3 |
| Moving Average 50 Days | 25.48 |
| Moving Average 200 Days | 25.08 |
Statistics
| Average Volume | 2.3M |
| Shares Outstanding | 125.69M |
| % Held by Institutions | 101.51 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
